nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—CHRM3—Carbachol—glaucoma	0.158	0.194	CbGbCtD
Trihexyphenidyl—CHRM3—Pilocarpine—glaucoma	0.147	0.18	CbGbCtD
Trihexyphenidyl—CHRM1—Carbachol—glaucoma	0.137	0.169	CbGbCtD
Trihexyphenidyl—CHRM1—Pilocarpine—glaucoma	0.128	0.157	CbGbCtD
Trihexyphenidyl—CHRM2—Carbachol—glaucoma	0.127	0.156	CbGbCtD
Trihexyphenidyl—CHRM2—Pilocarpine—glaucoma	0.118	0.145	CbGbCtD
Trihexyphenidyl—Parotitis—Clonidine—glaucoma	0.0177	0.0993	CcSEcCtD
Trihexyphenidyl—Mydriasis—Dipivefrin—glaucoma	0.00709	0.0397	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Brimonidine—glaucoma	0.00403	0.0226	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Brinzolamide—glaucoma	0.00378	0.0212	CcSEcCtD
Trihexyphenidyl—Blindness—Brimonidine—glaucoma	0.0032	0.0179	CcSEcCtD
Trihexyphenidyl—Sinus bradycardia—Clonidine—glaucoma	0.0026	0.0146	CcSEcCtD
Trihexyphenidyl—Mydriasis—Apraclonidine—glaucoma	0.00259	0.0145	CcSEcCtD
Trihexyphenidyl—Delusion—Pilocarpine—glaucoma	0.00226	0.0127	CcSEcCtD
Trihexyphenidyl—Accommodation disorder—Clonidine—glaucoma	0.00222	0.0125	CcSEcCtD
Trihexyphenidyl—Memory impairment—Brinzolamide—glaucoma	0.00212	0.0119	CcSEcCtD
Trihexyphenidyl—Mydriasis—Travoprost—glaucoma	0.00211	0.0118	CcSEcCtD
Trihexyphenidyl—Tachycardia—Dipivefrin—glaucoma	0.00197	0.011	CcSEcCtD
Trihexyphenidyl—Vision blurred—Echothiophate—glaucoma	0.00195	0.0109	CcSEcCtD
Trihexyphenidyl—Weight decreased—Diclofenamide—glaucoma	0.00164	0.00921	CcSEcCtD
Trihexyphenidyl—Drowsiness—Diclofenamide—glaucoma	0.00162	0.00908	CcSEcCtD
Trihexyphenidyl—Vomiting—Physostigmine—glaucoma	0.00151	0.00846	CcSEcCtD
Trihexyphenidyl—Drowsiness—Methazolamide—glaucoma	0.00149	0.00836	CcSEcCtD
Trihexyphenidyl—Nausea—Physostigmine—glaucoma	0.00141	0.0079	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Pilocarpine—glaucoma	0.00139	0.00781	CcSEcCtD
Trihexyphenidyl—Tension—Metipranolol—glaucoma	0.00136	0.00764	CcSEcCtD
Trihexyphenidyl—Nervousness—Metipranolol—glaucoma	0.00135	0.00756	CcSEcCtD
Trihexyphenidyl—Dry skin—Bimatoprost—glaucoma	0.00133	0.00746	CcSEcCtD
Trihexyphenidyl—Vision blurred—Metipranolol—glaucoma	0.00131	0.00734	CcSEcCtD
Trihexyphenidyl—Tension—Diclofenamide—glaucoma	0.00124	0.00696	CcSEcCtD
Trihexyphenidyl—Nervousness—Diclofenamide—glaucoma	0.00123	0.00689	CcSEcCtD
Trihexyphenidyl—Vision blurred—Carteolol—glaucoma	0.00121	0.0068	CcSEcCtD
Trihexyphenidyl—Dry skin—Brimonidine—glaucoma	0.00118	0.0066	CcSEcCtD
Trihexyphenidyl—Dry skin—Pilocarpine—glaucoma	0.00106	0.00596	CcSEcCtD
Trihexyphenidyl—Vision blurred—Latanoprost—glaucoma	0.00106	0.00596	CcSEcCtD
Trihexyphenidyl—Confusional state—Diclofenamide—glaucoma	0.00104	0.00584	CcSEcCtD
Trihexyphenidyl—Drowsiness—Acetazolamide—glaucoma	0.00103	0.00579	CcSEcCtD
Trihexyphenidyl—Somnolence—Metipranolol—glaucoma	0.00101	0.00565	CcSEcCtD
Trihexyphenidyl—Confusional state—Levobunolol—glaucoma	0.001	0.00561	CcSEcCtD
Trihexyphenidyl—Drowsiness—Brimonidine—glaucoma	0.000991	0.00555	CcSEcCtD
Trihexyphenidyl—Weight decreased—Dorzolamide—glaucoma	0.00096	0.00538	CcSEcCtD
Trihexyphenidyl—Confusional state—Methazolamide—glaucoma	0.000959	0.00538	CcSEcCtD
Trihexyphenidyl—Somnolence—Diclofenamide—glaucoma	0.000918	0.00515	CcSEcCtD
Trihexyphenidyl—Tension—Apraclonidine—glaucoma	0.000885	0.00496	CcSEcCtD
Trihexyphenidyl—Constipation—Diclofenamide—glaucoma	0.000883	0.00495	CcSEcCtD
Trihexyphenidyl—Nervousness—Apraclonidine—glaucoma	0.000876	0.00491	CcSEcCtD
Trihexyphenidyl—Tension—Bimatoprost—glaucoma	0.000858	0.00481	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Diclofenamide—glaucoma	0.000851	0.00477	CcSEcCtD
Trihexyphenidyl—Vision blurred—Apraclonidine—glaucoma	0.00085	0.00476	CcSEcCtD
Trihexyphenidyl—Nervousness—Bimatoprost—glaucoma	0.000849	0.00476	CcSEcCtD
Trihexyphenidyl—Somnolence—Methazolamide—glaucoma	0.000846	0.00474	CcSEcCtD
Trihexyphenidyl—Hallucination—Dorzolamide—glaucoma	0.000845	0.00474	CcSEcCtD
Trihexyphenidyl—Vision blurred—Bimatoprost—glaucoma	0.000824	0.00462	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Levobunolol—glaucoma	0.000818	0.00459	CcSEcCtD
Trihexyphenidyl—Asthenia—Metipranolol—glaucoma	0.000814	0.00456	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Betaxolol—glaucoma	0.000788	0.00442	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methazolamide—glaucoma	0.000784	0.00439	CcSEcCtD
Trihexyphenidyl—Asthenia—Carteolol—glaucoma	0.000754	0.00423	CcSEcCtD
Trihexyphenidyl—Dizziness—Metipranolol—glaucoma	0.00075	0.0042	CcSEcCtD
Trihexyphenidyl—Agitation—Acetazolamide—glaucoma	0.000741	0.00416	CcSEcCtD
Trihexyphenidyl—Asthenia—Diclofenamide—glaucoma	0.000741	0.00415	CcSEcCtD
Trihexyphenidyl—Vision blurred—Brimonidine—glaucoma	0.00073	0.00409	CcSEcCtD
Trihexyphenidyl—Tension—Dorzolamide—glaucoma	0.000726	0.00407	CcSEcCtD
Trihexyphenidyl—Nervousness—Dorzolamide—glaucoma	0.000718	0.00403	CcSEcCtD
Trihexyphenidyl—Rash—Metipranolol—glaucoma	0.000715	0.00401	CcSEcCtD
Trihexyphenidyl—Dermatitis—Metipranolol—glaucoma	0.000715	0.004	CcSEcCtD
Trihexyphenidyl—Drowsiness—Clonidine—glaucoma	0.000714	0.004	CcSEcCtD
Trihexyphenidyl—Tension—Brinzolamide—glaucoma	0.000713	0.004	CcSEcCtD
Trihexyphenidyl—Asthenia—Levobunolol—glaucoma	0.000712	0.00399	CcSEcCtD
Trihexyphenidyl—Headache—Metipranolol—glaucoma	0.000711	0.00398	CcSEcCtD
Trihexyphenidyl—Nervousness—Brinzolamide—glaucoma	0.000706	0.00396	CcSEcCtD
Trihexyphenidyl—Vision blurred—Dorzolamide—glaucoma	0.000697	0.00391	CcSEcCtD
Trihexyphenidyl—Dizziness—Carteolol—glaucoma	0.000695	0.00389	CcSEcCtD
Trihexyphenidyl—Vision blurred—Travoprost—glaucoma	0.000694	0.00389	CcSEcCtD
Trihexyphenidyl—Tension—Pilocarpine—glaucoma	0.000686	0.00384	CcSEcCtD
Trihexyphenidyl—Vision blurred—Brinzolamide—glaucoma	0.000685	0.00384	CcSEcCtD
Trihexyphenidyl—Dizziness—Diclofenamide—glaucoma	0.000683	0.00383	CcSEcCtD
Trihexyphenidyl—Asthenia—Methazolamide—glaucoma	0.000683	0.00382	CcSEcCtD
Trihexyphenidyl—Nervousness—Pilocarpine—glaucoma	0.000679	0.0038	CcSEcCtD
Trihexyphenidyl—Nausea—Metipranolol—glaucoma	0.000674	0.00378	CcSEcCtD
Trihexyphenidyl—Agitation—Brinzolamide—glaucoma	0.000668	0.00374	CcSEcCtD
Trihexyphenidyl—Dizziness—Carbachol—glaucoma	0.000667	0.00374	CcSEcCtD
Trihexyphenidyl—Confusional state—Acetazolamide—glaucoma	0.000664	0.00372	CcSEcCtD
Trihexyphenidyl—Vision blurred—Pilocarpine—glaucoma	0.000659	0.00369	CcSEcCtD
Trihexyphenidyl—Headache—Carteolol—glaucoma	0.000658	0.00369	CcSEcCtD
Trihexyphenidyl—Vomiting—Diclofenamide—glaucoma	0.000657	0.00368	CcSEcCtD
Trihexyphenidyl—Dizziness—Levobunolol—glaucoma	0.000657	0.00368	CcSEcCtD
Trihexyphenidyl—Somnolence—Apraclonidine—glaucoma	0.000654	0.00367	CcSEcCtD
Trihexyphenidyl—Rash—Diclofenamide—glaucoma	0.000651	0.00365	CcSEcCtD
Trihexyphenidyl—Headache—Diclofenamide—glaucoma	0.000647	0.00363	CcSEcCtD
Trihexyphenidyl—Agitation—Pilocarpine—glaucoma	0.000642	0.0036	CcSEcCtD
Trihexyphenidyl—Vomiting—Carbachol—glaucoma	0.000641	0.00359	CcSEcCtD
Trihexyphenidyl—Hallucination—Clonidine—glaucoma	0.000638	0.00357	CcSEcCtD
Trihexyphenidyl—Rash—Carbachol—glaucoma	0.000636	0.00356	CcSEcCtD
Trihexyphenidyl—Dermatitis—Carbachol—glaucoma	0.000635	0.00356	CcSEcCtD
Trihexyphenidyl—Somnolence—Bimatoprost—glaucoma	0.000634	0.00356	CcSEcCtD
Trihexyphenidyl—Headache—Carbachol—glaucoma	0.000632	0.00354	CcSEcCtD
Trihexyphenidyl—Weight decreased—Betaxolol—glaucoma	0.000631	0.00354	CcSEcCtD
Trihexyphenidyl—Constipation—Apraclonidine—glaucoma	0.000629	0.00353	CcSEcCtD
Trihexyphenidyl—Nausea—Carteolol—glaucoma	0.000624	0.0035	CcSEcCtD
Trihexyphenidyl—Headache—Levobunolol—glaucoma	0.000622	0.00349	CcSEcCtD
Trihexyphenidyl—Tachycardia—Brimonidine—glaucoma	0.000617	0.00346	CcSEcCtD
Trihexyphenidyl—Nausea—Diclofenamide—glaucoma	0.000614	0.00344	CcSEcCtD
Trihexyphenidyl—Dizziness—Latanoprost—glaucoma	0.000609	0.00341	CcSEcCtD
Trihexyphenidyl—Confusional state—Dorzolamide—glaucoma	0.000609	0.00341	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Apraclonidine—glaucoma	0.000607	0.0034	CcSEcCtD
Trihexyphenidyl—Vomiting—Methazolamide—glaucoma	0.000605	0.00339	CcSEcCtD
Trihexyphenidyl—Rash—Methazolamide—glaucoma	0.0006	0.00336	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methazolamide—glaucoma	0.000599	0.00336	CcSEcCtD
Trihexyphenidyl—Nausea—Carbachol—glaucoma	0.000599	0.00336	CcSEcCtD
Trihexyphenidyl—Headache—Methazolamide—glaucoma	0.000596	0.00334	CcSEcCtD
Trihexyphenidyl—Nausea—Levobunolol—glaucoma	0.00059	0.00331	CcSEcCtD
Trihexyphenidyl—Tachycardia—Travoprost—glaucoma	0.000587	0.00329	CcSEcCtD
Trihexyphenidyl—Somnolence—Acetazolamide—glaucoma	0.000585	0.00328	CcSEcCtD
Trihexyphenidyl—Rash—Latanoprost—glaucoma	0.000581	0.00325	CcSEcCtD
Trihexyphenidyl—Dermatitis—Latanoprost—glaucoma	0.00058	0.00325	CcSEcCtD
Trihexyphenidyl—Tachycardia—Brinzolamide—glaucoma	0.000579	0.00325	CcSEcCtD
Trihexyphenidyl—Headache—Latanoprost—glaucoma	0.000577	0.00323	CcSEcCtD
Trihexyphenidyl—Confusional state—Pilocarpine—glaucoma	0.000575	0.00322	CcSEcCtD
Trihexyphenidyl—Nausea—Methazolamide—glaucoma	0.000565	0.00317	CcSEcCtD
Trihexyphenidyl—Somnolence—Brimonidine—glaucoma	0.000562	0.00315	CcSEcCtD
Trihexyphenidyl—Tachycardia—Pilocarpine—glaucoma	0.000557	0.00312	CcSEcCtD
Trihexyphenidyl—Hallucination—Betaxolol—glaucoma	0.000555	0.00311	CcSEcCtD
Trihexyphenidyl—Tension—Clonidine—glaucoma	0.000548	0.00307	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Acetazolamide—glaucoma	0.000543	0.00304	CcSEcCtD
Trihexyphenidyl—Nervousness—Clonidine—glaucoma	0.000542	0.00304	CcSEcCtD
Trihexyphenidyl—Somnolence—Dorzolamide—glaucoma	0.000537	0.00301	CcSEcCtD
Trihexyphenidyl—Asthenia—Apraclonidine—glaucoma	0.000528	0.00296	CcSEcCtD
Trihexyphenidyl—Somnolence—Brinzolamide—glaucoma	0.000527	0.00296	CcSEcCtD
Trihexyphenidyl—Vision blurred—Clonidine—glaucoma	0.000526	0.00295	CcSEcCtD
Trihexyphenidyl—Weight decreased—Timolol—glaucoma	0.000515	0.00289	CcSEcCtD
Trihexyphenidyl—Constipation—Travoprost—glaucoma	0.000514	0.00288	CcSEcCtD
Trihexyphenidyl—Agitation—Clonidine—glaucoma	0.000513	0.00287	CcSEcCtD
Trihexyphenidyl—Asthenia—Bimatoprost—glaucoma	0.000512	0.00287	CcSEcCtD
Trihexyphenidyl—Somnolence—Pilocarpine—glaucoma	0.000507	0.00284	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dorzolamide—glaucoma	0.000497	0.00279	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Travoprost—glaucoma	0.000495	0.00278	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Brinzolamide—glaucoma	0.000489	0.00274	CcSEcCtD
Trihexyphenidyl—Constipation—Pilocarpine—glaucoma	0.000488	0.00273	CcSEcCtD
Trihexyphenidyl—Dizziness—Apraclonidine—glaucoma	0.000487	0.00273	CcSEcCtD
Trihexyphenidyl—Tension—Betaxolol—glaucoma	0.000477	0.00267	CcSEcCtD
Trihexyphenidyl—Asthenia—Acetazolamide—glaucoma	0.000472	0.00265	CcSEcCtD
Trihexyphenidyl—Dizziness—Bimatoprost—glaucoma	0.000472	0.00264	CcSEcCtD
Trihexyphenidyl—Nervousness—Betaxolol—glaucoma	0.000472	0.00264	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Pilocarpine—glaucoma	0.00047	0.00263	CcSEcCtD
Trihexyphenidyl—Vomiting—Apraclonidine—glaucoma	0.000468	0.00262	CcSEcCtD
Trihexyphenidyl—Dermatitis—Apraclonidine—glaucoma	0.000464	0.0026	CcSEcCtD
Trihexyphenidyl—Headache—Apraclonidine—glaucoma	0.000461	0.00258	CcSEcCtD
Trihexyphenidyl—Confusional state—Clonidine—glaucoma	0.000459	0.00257	CcSEcCtD
Trihexyphenidyl—Vision blurred—Betaxolol—glaucoma	0.000458	0.00257	CcSEcCtD
Trihexyphenidyl—Hallucination—Timolol—glaucoma	0.000454	0.00254	CcSEcCtD
Trihexyphenidyl—Asthenia—Brimonidine—glaucoma	0.000453	0.00254	CcSEcCtD
Trihexyphenidyl—Rash—Bimatoprost—glaucoma	0.00045	0.00252	CcSEcCtD
Trihexyphenidyl—Dermatitis—Bimatoprost—glaucoma	0.00045	0.00252	CcSEcCtD
Trihexyphenidyl—Headache—Bimatoprost—glaucoma	0.000447	0.00251	CcSEcCtD
Trihexyphenidyl—Tachycardia—Clonidine—glaucoma	0.000444	0.00249	CcSEcCtD
Trihexyphenidyl—Nausea—Apraclonidine—glaucoma	0.000437	0.00245	CcSEcCtD
Trihexyphenidyl—Dizziness—Acetazolamide—glaucoma	0.000435	0.00244	CcSEcCtD
Trihexyphenidyl—Asthenia—Dorzolamide—glaucoma	0.000433	0.00243	CcSEcCtD
Trihexyphenidyl—Asthenia—Travoprost—glaucoma	0.000431	0.00242	CcSEcCtD
Trihexyphenidyl—Asthenia—Brinzolamide—glaucoma	0.000426	0.00239	CcSEcCtD
Trihexyphenidyl—Nausea—Bimatoprost—glaucoma	0.000424	0.00238	CcSEcCtD
Trihexyphenidyl—Vomiting—Acetazolamide—glaucoma	0.000419	0.00235	CcSEcCtD
Trihexyphenidyl—Dizziness—Brimonidine—glaucoma	0.000418	0.00234	CcSEcCtD
Trihexyphenidyl—Headache—Acetazolamide—glaucoma	0.000413	0.00231	CcSEcCtD
Trihexyphenidyl—Asthenia—Pilocarpine—glaucoma	0.000409	0.00229	CcSEcCtD
Trihexyphenidyl—Somnolence—Clonidine—glaucoma	0.000405	0.00227	CcSEcCtD
Trihexyphenidyl—Confusional state—Betaxolol—glaucoma	0.0004	0.00224	CcSEcCtD
Trihexyphenidyl—Dizziness—Dorzolamide—glaucoma	0.000399	0.00224	CcSEcCtD
Trihexyphenidyl—Rash—Brimonidine—glaucoma	0.000398	0.00223	CcSEcCtD
Trihexyphenidyl—Dermatitis—Brimonidine—glaucoma	0.000398	0.00223	CcSEcCtD
Trihexyphenidyl—Dizziness—Travoprost—glaucoma	0.000397	0.00223	CcSEcCtD
Trihexyphenidyl—Headache—Brimonidine—glaucoma	0.000396	0.00222	CcSEcCtD
Trihexyphenidyl—Dizziness—Brinzolamide—glaucoma	0.000392	0.0022	CcSEcCtD
Trihexyphenidyl—Nausea—Acetazolamide—glaucoma	0.000391	0.00219	CcSEcCtD
Trihexyphenidyl—Tension—Timolol—glaucoma	0.000389	0.00218	CcSEcCtD
Trihexyphenidyl—Constipation—Clonidine—glaucoma	0.000389	0.00218	CcSEcCtD
Trihexyphenidyl—Tachycardia—Betaxolol—glaucoma	0.000387	0.00217	CcSEcCtD
Trihexyphenidyl—Nervousness—Timolol—glaucoma	0.000385	0.00216	CcSEcCtD
Trihexyphenidyl—Vomiting—Dorzolamide—glaucoma	0.000384	0.00215	CcSEcCtD
Trihexyphenidyl—Rash—Dorzolamide—glaucoma	0.000381	0.00213	CcSEcCtD
Trihexyphenidyl—Dermatitis—Dorzolamide—glaucoma	0.00038	0.00213	CcSEcCtD
Trihexyphenidyl—Rash—Travoprost—glaucoma	0.000379	0.00212	CcSEcCtD
Trihexyphenidyl—Dermatitis—Travoprost—glaucoma	0.000379	0.00212	CcSEcCtD
Trihexyphenidyl—Headache—Dorzolamide—glaucoma	0.000378	0.00212	CcSEcCtD
Trihexyphenidyl—Vomiting—Brinzolamide—glaucoma	0.000377	0.00211	CcSEcCtD
Trihexyphenidyl—Dizziness—Pilocarpine—glaucoma	0.000377	0.00211	CcSEcCtD
Trihexyphenidyl—Headache—Travoprost—glaucoma	0.000376	0.00211	CcSEcCtD
Trihexyphenidyl—Nausea—Brimonidine—glaucoma	0.000375	0.0021	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Clonidine—glaucoma	0.000375	0.0021	CcSEcCtD
Trihexyphenidyl—Rash—Brinzolamide—glaucoma	0.000374	0.0021	CcSEcCtD
Trihexyphenidyl—Vision blurred—Timolol—glaucoma	0.000374	0.0021	CcSEcCtD
Trihexyphenidyl—Dermatitis—Brinzolamide—glaucoma	0.000374	0.00209	CcSEcCtD
Trihexyphenidyl—Headache—Brinzolamide—glaucoma	0.000372	0.00208	CcSEcCtD
Trihexyphenidyl—Vomiting—Pilocarpine—glaucoma	0.000363	0.00203	CcSEcCtD
Trihexyphenidyl—Rash—Pilocarpine—glaucoma	0.00036	0.00202	CcSEcCtD
Trihexyphenidyl—Dermatitis—Pilocarpine—glaucoma	0.000359	0.00201	CcSEcCtD
Trihexyphenidyl—Nausea—Dorzolamide—glaucoma	0.000358	0.00201	CcSEcCtD
Trihexyphenidyl—Headache—Pilocarpine—glaucoma	0.000357	0.002	CcSEcCtD
Trihexyphenidyl—Nausea—Travoprost—glaucoma	0.000357	0.002	CcSEcCtD
Trihexyphenidyl—Nausea—Brinzolamide—glaucoma	0.000352	0.00198	CcSEcCtD
Trihexyphenidyl—Constipation—Betaxolol—glaucoma	0.000339	0.0019	CcSEcCtD
Trihexyphenidyl—Nausea—Pilocarpine—glaucoma	0.000339	0.0019	CcSEcCtD
Trihexyphenidyl—Asthenia—Clonidine—glaucoma	0.000327	0.00183	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Betaxolol—glaucoma	0.000327	0.00183	CcSEcCtD
Trihexyphenidyl—Confusional state—Timolol—glaucoma	0.000327	0.00183	CcSEcCtD
Trihexyphenidyl—Dizziness—Clonidine—glaucoma	0.000301	0.00169	CcSEcCtD
Trihexyphenidyl—Vomiting—Clonidine—glaucoma	0.00029	0.00162	CcSEcCtD
Trihexyphenidyl—Somnolence—Timolol—glaucoma	0.000288	0.00161	CcSEcCtD
Trihexyphenidyl—Rash—Clonidine—glaucoma	0.000287	0.00161	CcSEcCtD
Trihexyphenidyl—Dermatitis—Clonidine—glaucoma	0.000287	0.00161	CcSEcCtD
Trihexyphenidyl—Headache—Clonidine—glaucoma	0.000285	0.0016	CcSEcCtD
Trihexyphenidyl—Asthenia—Betaxolol—glaucoma	0.000284	0.00159	CcSEcCtD
Trihexyphenidyl—Nausea—Clonidine—glaucoma	0.000271	0.00152	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Timolol—glaucoma	0.000267	0.0015	CcSEcCtD
Trihexyphenidyl—Dizziness—Betaxolol—glaucoma	0.000262	0.00147	CcSEcCtD
Trihexyphenidyl—Vomiting—Betaxolol—glaucoma	0.000252	0.00141	CcSEcCtD
Trihexyphenidyl—Rash—Betaxolol—glaucoma	0.00025	0.0014	CcSEcCtD
Trihexyphenidyl—Dermatitis—Betaxolol—glaucoma	0.00025	0.0014	CcSEcCtD
Trihexyphenidyl—Headache—Betaxolol—glaucoma	0.000248	0.00139	CcSEcCtD
Trihexyphenidyl—Nausea—Betaxolol—glaucoma	0.000236	0.00132	CcSEcCtD
Trihexyphenidyl—Asthenia—Timolol—glaucoma	0.000232	0.0013	CcSEcCtD
Trihexyphenidyl—Dizziness—Timolol—glaucoma	0.000214	0.0012	CcSEcCtD
Trihexyphenidyl—Vomiting—Timolol—glaucoma	0.000206	0.00115	CcSEcCtD
Trihexyphenidyl—Rash—Timolol—glaucoma	0.000204	0.00114	CcSEcCtD
Trihexyphenidyl—Dermatitis—Timolol—glaucoma	0.000204	0.00114	CcSEcCtD
Trihexyphenidyl—Headache—Timolol—glaucoma	0.000203	0.00114	CcSEcCtD
Trihexyphenidyl—Nausea—Timolol—glaucoma	0.000192	0.00108	CcSEcCtD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	5.99e-05	0.00876	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—OPN4—glaucoma	5.87e-05	0.00859	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—OPN4—glaucoma	5.62e-05	0.00823	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	5.46e-05	0.00799	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	5.44e-05	0.00797	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	5.39e-05	0.00789	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—PTGFR—glaucoma	5.28e-05	0.00773	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	5.2e-05	0.00761	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—HDAC9—glaucoma	5.2e-05	0.0076	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	5.18e-05	0.00758	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	5.13e-05	0.00751	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—PTGFR—glaucoma	5.06e-05	0.00741	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	4.68e-05	0.00685	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	4.66e-05	0.00683	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	4.62e-05	0.00676	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—OPN4—glaucoma	3.96e-05	0.00579	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—OPN4—glaucoma	3.95e-05	0.00577	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—OPN4—glaucoma	3.91e-05	0.00572	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—NTRK2—glaucoma	3.72e-05	0.00544	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—PTGFR—glaucoma	3.56e-05	0.00521	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—PTGFR—glaucoma	3.55e-05	0.0052	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—PTGFR—glaucoma	3.52e-05	0.00515	CbGpPWpGaD
Trihexyphenidyl—CHRM5—G alpha (q) signalling events—EDN1—glaucoma	3.34e-05	0.00488	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—OPN4—glaucoma	3.32e-05	0.00485	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.2e-05	0.00469	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—OPN4—glaucoma	3.18e-05	0.00465	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.07e-05	0.00449	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—OPN4—glaucoma	3.01e-05	0.00441	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—PTGFR—glaucoma	2.99e-05	0.00437	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.98e-05	0.00437	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—OPN4—glaucoma	2.88e-05	0.00422	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—PTGFR—glaucoma	2.86e-05	0.00419	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—BDNF—glaucoma	2.78e-05	0.00406	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—NARFL—glaucoma	2.72e-05	0.00398	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CA5A—glaucoma	2.72e-05	0.00398	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PTGFR—glaucoma	2.71e-05	0.00397	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—IL1A—glaucoma	2.66e-05	0.0039	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—SMO—glaucoma	2.66e-05	0.0039	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—NGFR—glaucoma	2.64e-05	0.00386	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PTGFR—glaucoma	2.6e-05	0.0038	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—LRP12—glaucoma	2.57e-05	0.00376	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—SMO—glaucoma	2.55e-05	0.00373	CbGpPWpGaD
Trihexyphenidyl—CHRM4—G alpha (i) signalling events—C3—glaucoma	2.53e-05	0.00371	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	2.51e-05	0.00367	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	2.46e-05	0.00361	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—LRP12—glaucoma	2.46e-05	0.0036	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	2.45e-05	0.00359	CbGpPWpGaD
Trihexyphenidyl—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	2.35e-05	0.00344	CbGpPWpGaD
Trihexyphenidyl—CHRM3—G alpha (q) signalling events—EDN1—glaucoma	2.34e-05	0.00343	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.31e-05	0.00338	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—OPN4—glaucoma	2.24e-05	0.00327	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—OPN4—glaucoma	2.23e-05	0.00326	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.21e-05	0.00323	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—OPN4—glaucoma	2.21e-05	0.00323	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.16e-05	0.00316	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.15e-05	0.00315	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.13e-05	0.00312	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.1e-05	0.00307	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.09e-05	0.00306	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—OPN4—glaucoma	2.03e-05	0.00297	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—OPN4—glaucoma	2.02e-05	0.00296	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.02e-05	0.00295	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	2.01e-05	0.00295	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PTGFR—glaucoma	2.01e-05	0.00294	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—OPN4—glaucoma	2e-05	0.00293	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	1.99e-05	0.00291	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—FAS—glaucoma	1.96e-05	0.00288	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.93e-05	0.00282	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PTGFR—glaucoma	1.83e-05	0.00268	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PTGFR—glaucoma	1.82e-05	0.00267	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PTGFR—glaucoma	1.81e-05	0.00264	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—SMO—glaucoma	1.8e-05	0.00263	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—SMO—glaucoma	1.79e-05	0.00262	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—OPN4—glaucoma	1.78e-05	0.0026	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—SMO—glaucoma	1.77e-05	0.0026	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—EDN1—glaucoma	1.76e-05	0.00257	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—LRP12—glaucoma	1.73e-05	0.00253	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—LRP12—glaucoma	1.73e-05	0.00253	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—LRP12—glaucoma	1.71e-05	0.0025	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—OPN4—glaucoma	1.7e-05	0.00249	CbGpPWpGaD
Trihexyphenidyl—CHRM2—G alpha (i) signalling events—C3—glaucoma	1.69e-05	0.00247	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—EDN1—glaucoma	1.68e-05	0.00246	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HEYL—glaucoma	1.65e-05	0.00242	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PTGFR—glaucoma	1.6e-05	0.00234	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HEYL—glaucoma	1.58e-05	0.00232	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.56e-05	0.00228	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.55e-05	0.00227	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.54e-05	0.00225	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—C3—glaucoma	1.53e-05	0.00225	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PTGFR—glaucoma	1.53e-05	0.00225	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—C3—glaucoma	1.47e-05	0.00215	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—SMO—glaucoma	1.37e-05	0.002	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.36e-05	0.00199	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.35e-05	0.00198	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.34e-05	0.00196	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CA1—glaucoma	1.33e-05	0.00195	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—SMO—glaucoma	1.31e-05	0.00192	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CTSA—glaucoma	1.29e-05	0.00188	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RPTOR—glaucoma	1.25e-05	0.00183	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CA2—glaucoma	1.22e-05	0.00178	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NCK2—glaucoma	1.21e-05	0.00178	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RPTOR—glaucoma	1.2e-05	0.00176	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—OPN4—glaucoma	1.2e-05	0.00176	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—OPN4—glaucoma	1.2e-05	0.00175	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—EDN1—glaucoma	1.18e-05	0.00173	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—OPN4—glaucoma	1.18e-05	0.00173	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—EDN1—glaucoma	1.18e-05	0.00173	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.18e-05	0.00172	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—EDN1—glaucoma	1.17e-05	0.00171	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NCK2—glaucoma	1.16e-05	0.0017	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HEYL—glaucoma	1.12e-05	0.00163	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HEYL—glaucoma	1.11e-05	0.00163	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HEYL—glaucoma	1.1e-05	0.00161	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PTGFR—glaucoma	1.08e-05	0.00158	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PTGFR—glaucoma	1.08e-05	0.00158	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PTGFR—glaucoma	1.07e-05	0.00156	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—C3—glaucoma	1.03e-05	0.00151	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HDAC9—glaucoma	1.03e-05	0.00151	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—C3—glaucoma	1.03e-05	0.00151	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—C3—glaucoma	1.02e-05	0.0015	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	1.01e-05	0.00148	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—EDN1—glaucoma	9.93e-06	0.00145	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HDAC9—glaucoma	9.89e-06	0.00145	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—EDN1—glaucoma	9.51e-06	0.00139	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—SMO—glaucoma	9.22e-06	0.00135	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—SMO—glaucoma	9.19e-06	0.00135	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—SMO—glaucoma	9.1e-06	0.00133	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—EDN1—glaucoma	9.02e-06	0.00132	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—C3—glaucoma	8.67e-06	0.00127	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EDN1—glaucoma	8.63e-06	0.00126	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—TXN—glaucoma	8.57e-06	0.00125	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RPTOR—glaucoma	8.45e-06	0.00124	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RPTOR—glaucoma	8.43e-06	0.00123	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RPTOR—glaucoma	8.34e-06	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—C3—glaucoma	8.31e-06	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NCK2—glaucoma	8.19e-06	0.0012	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NCK2—glaucoma	8.16e-06	0.00119	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NCK2—glaucoma	8.08e-06	0.00118	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SMO—glaucoma	8.08e-06	0.00118	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—C3—glaucoma	7.88e-06	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SMO—glaucoma	7.74e-06	0.00113	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—C3—glaucoma	7.54e-06	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NTRK2—glaucoma	7.39e-06	0.00108	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—TP53—glaucoma	7.35e-06	0.00108	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NTRK2—glaucoma	7.08e-06	0.00104	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HDAC9—glaucoma	6.96e-06	0.00102	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HDAC9—glaucoma	6.94e-06	0.00102	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HDAC9—glaucoma	6.87e-06	0.00101	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—EDN1—glaucoma	6.69e-06	0.00098	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—EDN1—glaucoma	6.67e-06	0.000977	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTT1—glaucoma	6.64e-06	0.000972	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—EDN1—glaucoma	6.61e-06	0.000967	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NGFR—glaucoma	6.34e-06	0.000928	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EDN1—glaucoma	6.08e-06	0.00089	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NGFR—glaucoma	6.07e-06	0.000888	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EDN1—glaucoma	6.06e-06	0.000887	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NTRK1—glaucoma	6.02e-06	0.000881	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EDN1—glaucoma	6e-06	0.000878	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—C3—glaucoma	5.85e-06	0.000856	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—C3—glaucoma	5.83e-06	0.000853	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—C3—glaucoma	5.77e-06	0.000845	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NTRK1—glaucoma	5.77e-06	0.000844	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CDKN2B—glaucoma	5.55e-06	0.000812	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SMO—glaucoma	5.45e-06	0.000797	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SMO—glaucoma	5.43e-06	0.000795	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SMO—glaucoma	5.38e-06	0.000787	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EDN1—glaucoma	5.33e-06	0.000779	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CDKN2B—glaucoma	5.32e-06	0.000778	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—C3—glaucoma	5.31e-06	0.000777	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—C3—glaucoma	5.29e-06	0.000775	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ABCA1—glaucoma	5.29e-06	0.000775	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CYP1B1—glaucoma	5.29e-06	0.000775	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—C3—glaucoma	5.24e-06	0.000767	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EDN1—glaucoma	5.1e-06	0.000746	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NTRK2—glaucoma	4.98e-06	0.000729	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NTRK2—glaucoma	4.97e-06	0.000727	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NTRK2—glaucoma	4.92e-06	0.00072	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NGF—glaucoma	4.89e-06	0.000716	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NGF—glaucoma	4.69e-06	0.000686	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—C3—glaucoma	4.65e-06	0.000681	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—C3—glaucoma	4.46e-06	0.000652	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APOE—glaucoma	4.33e-06	0.000634	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CAV1—glaucoma	4.29e-06	0.000628	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NGFR—glaucoma	4.27e-06	0.000626	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NGFR—glaucoma	4.26e-06	0.000624	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTM1—glaucoma	4.23e-06	0.000619	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NGFR—glaucoma	4.22e-06	0.000618	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APOE—glaucoma	4.15e-06	0.000607	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CAV1—glaucoma	4.11e-06	0.000601	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—FN1—glaucoma	4.08e-06	0.000598	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NTRK1—glaucoma	4.06e-06	0.000594	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NTRK1—glaucoma	4.05e-06	0.000592	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—BAD—glaucoma	4.04e-06	0.000591	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NTRK1—glaucoma	4.01e-06	0.000587	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—FN1—glaucoma	3.91e-06	0.000573	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—BAD—glaucoma	3.87e-06	0.000566	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDKN2B—glaucoma	3.74e-06	0.000548	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MTHFR—glaucoma	3.74e-06	0.000547	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDKN2B—glaucoma	3.73e-06	0.000546	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDKN2B—glaucoma	3.69e-06	0.000541	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EDN1—glaucoma	3.59e-06	0.000526	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EDN1—glaucoma	3.58e-06	0.000524	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EDN1—glaucoma	3.55e-06	0.000519	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOE—glaucoma	3.48e-06	0.00051	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CAV1—glaucoma	3.45e-06	0.000505	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NGF—glaucoma	3.3e-06	0.000483	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NGF—glaucoma	3.29e-06	0.000481	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NGF—glaucoma	3.26e-06	0.000477	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NOS3—glaucoma	3.25e-06	0.000475	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—C3—glaucoma	3.14e-06	0.000459	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—C3—glaucoma	3.13e-06	0.000458	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NOS3—glaucoma	3.11e-06	0.000455	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—C3—glaucoma	3.1e-06	0.000453	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOE—glaucoma	2.92e-06	0.000427	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOE—glaucoma	2.91e-06	0.000426	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CAV1—glaucoma	2.89e-06	0.000424	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CAV1—glaucoma	2.88e-06	0.000422	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOE—glaucoma	2.88e-06	0.000422	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CAV1—glaucoma	2.86e-06	0.000418	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CDKN1B—glaucoma	2.81e-06	0.000411	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FN1—glaucoma	2.75e-06	0.000403	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FN1—glaucoma	2.75e-06	0.000402	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—BAD—glaucoma	2.72e-06	0.000398	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FN1—glaucoma	2.72e-06	0.000398	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—BAD—glaucoma	2.71e-06	0.000397	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CDKN1B—glaucoma	2.69e-06	0.000394	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—BAD—glaucoma	2.69e-06	0.000393	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—NOS3—glaucoma	2.61e-06	0.000382	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MMP9—glaucoma	2.6e-06	0.000381	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MMP9—glaucoma	2.49e-06	0.000365	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—glaucoma	2.39e-06	0.000349	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—VEGFA—glaucoma	2.34e-06	0.000342	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—VEGFA—glaucoma	2.24e-06	0.000328	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOS3—glaucoma	2.19e-06	0.00032	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOS3—glaucoma	2.18e-06	0.000319	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOS3—glaucoma	2.16e-06	0.000316	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDKN1B—glaucoma	1.9e-06	0.000277	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDKN1B—glaucoma	1.89e-06	0.000277	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDKN1B—glaucoma	1.87e-06	0.000274	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TP53—glaucoma	1.77e-06	0.000259	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MMP9—glaucoma	1.76e-06	0.000257	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MMP9—glaucoma	1.75e-06	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MMP9—glaucoma	1.73e-06	0.000254	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TP53—glaucoma	1.69e-06	0.000248	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—VEGFA—glaucoma	1.58e-06	0.000231	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—VEGFA—glaucoma	1.57e-06	0.00023	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—VEGFA—glaucoma	1.56e-06	0.000228	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TP53—glaucoma	1.19e-06	0.000174	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TP53—glaucoma	1.19e-06	0.000174	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TP53—glaucoma	1.18e-06	0.000172	CbGpPWpGaD
